 - Biologic anti-neoplastic agent: Must not have received within 7 days of entry onto this study 21 days if prior VEGF-Trap and at least 3 half-lives after last dose of a monoclonal antibody. For biologic agents that have known adverse events occurring beyond 7 days after administration, this period must be extended beyond the time during which adverse events are known to occur; 